A STEP FORWARD: The team found that inhibiting the succinate levels in mice increased their survival rate and that succinate levels could be used as a biomarker
Taipei Times
Date: Jan 21, 2020
By: Lee I-chia / Staff reporter
The National Health Research Institutes (NHRI) yesterday said it had discovered that succinate
levels in blood serum could serve as a potential biomarker for lung cancer progression, and that inhibiting succinate levels might reduce the risk of lung cancer metastasis.NHRI Institute of Cellular and System Medicine associate researcher Kuo Cheng-chin (郭呈欽) said that cancer has been the most common cause of death in Taiwan for many years.
Among them, non-small cell lung cancer has a relatively poor prognosis, he said.
As there is no effective screening method for non-small cell lung cancer, patients are usually diagnosed in the later stages, he added. [FULL STORY]